ArticlePloS one2026
Bovine brucellosis seropositivity in Mpumalanga Province, South Africa, 2021-2024: Temporal, and spatial trends.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionBovine brucellosis, caused primarily by Brucella abortus, remains a major constraint to livestock productivity and a persistent zoonotic threat. Although brucellosis is a controlled disease in South Africa, detailed subnational epidemiological evidence is limited, particularly for Mpumalanga Province. Understanding temporal, seasonal, and spatial patterns is essential for improving risk-based surveillance and control. MATERIALS AND
methodsA retrospective cross-sectional analysis was conducted using routine diagnostic records from the Mpumalanga Provincial Veterinary Laboratory between January 2021 and December 2024. Rose Bengal Test (RBT) results from cattle originating from 17 Local Municipality Areas (LMAs) were analysed. Annual, seasonal, and spatial seroprevalence estimates were calculated, and independent predictors of RBT seropositivity were evaluated using multivariable logistic regression.
resultsA total of 67,974 cattle serum samples were tested, of which 6,182 were RBT-positive, yielding an overall seroprevalence of 9.1% (95% CI: 8.9-9.3). Annual seroprevalence increased from 6.9% in 2021 to 7.4% in 2022, peaked at 13.1% in 2023, and declined to 7.5% in 2024. Clear seasonal variation was observed, with higher seroprevalence in spring (10.6%) and summer (10.2%) compared with autumn (6.8%) and winter (6.9%). Pronounced spatial heterogeneity was evident, with Emalahleni (13.3%), Victor Khanye (13.0%), and Mbombela (12.0%) identified as high-burden municipalities, while Mkhondo (1.7%) and Albert Luthuli (2.7%) recorded the lowest prevalence. In adjusted analyses, testing in 2023 was associated with nearly double the odds of seropositivity compared with 2021 (AOR 1.95; 95% CI: 1.81-2.11), and spring and summer remained significant predictors.
conclusionBovine brucellosis in Mpumalanga exhibits marked temporal variability, seasonal peaks, and spatial clustering. These findings support targeted, risk-based surveillance, strategically timed vaccination, and strengthened biosecurity, prioritising hotspot municipalities and high-risk seasons within a One Health framework.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.